Indication
Non-muscular Invasive Bladder Cancer
2 clinical trials
1 product
Clinical trial
Phase I Clinical Trial to Evaluate the Safety and Tolerability of BCG for Therapeutic Use in Preventing Postoperative Recurrence of Non-muscular Invasive Bladder Cancer in People Aged 18 and OverStatus: Recruiting, Estimated PCD: 2025-05-01
Product
BCGClinical trial
A Phase I Clinical Study to Investigate the Safety and Tolerance of Therapeutic Bacillus Calmette-Guerin( BCG) in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)Status: Completed, Estimated PCD: 2023-02-13